Dynagenix® (Muscle + Joint Recovery Formula)

Boswellia serrata / Curcuma longa
Evidence Level
Strong
2 Clinical Trials
3 Documented Benefits
4/5 Evidence Score

Dynagenix® (PLT Health Solutions) is a beverage-friendly muscle and joint recovery formula clinically demonstrated to reduce muscle and joint soreness, accelerate recovery, and improve mobility — with rapid joint comfort improvement within 5 days. Two published clinical studies confirm Dynagenix® efficacy for both muscle recovery from exercise-induced damage and joint mobility in active populations. The formula's beverage-compatible form factor makes it uniquely suited for RTD, powder, and functional food applications.

Studied Dose Per Dynagenix® clinical dosing in published studies; PLT Health Solutions product specifications; rapid joint comfort within 5 days; muscle recovery benefits within 24–48 hours post-exercise
Active Compound Proprietary anti-inflammatory botanical blend — Dynagenix® by PLT Health Solutions; beverage-friendly formula combining muscle recovery and joint support actives; specific formulation per PLT product sheet

Rapid joint comfort within 5 days

A published clinical study on Dynagenix® demonstrated significant joint comfort improvement within 5 days of supplementation — one of the fastest-acting joint health outcomes documented for a natural ingredient. This rapid onset is particularly valuable for active individuals experiencing exercise-induced joint stress or for consumers seeking quick symptomatic relief.

Muscle recovery and soreness reduction

A second clinical study confirmed Dynagenix® accelerates recovery from exercise-induced muscle damage — reducing perceived muscle soreness, improving range of motion post-exercise, and shortening the time to return to full training capacity. The anti-inflammatory mechanism addresses both the muscle damage and joint stress that accumulate with regular training.

Mobility improvement and functional movement

Dynagenix® improves functional mobility metrics — range of motion, movement quality, and ease of physical activity — through its combined muscle and joint anti-inflammatory action. This dual benefit profile positions it for both sports recovery and healthy aging mobility applications.

1

Multi-pathway anti-inflammatory muscle and joint support

Dynagenix® targets the inflammatory pathways driving both muscle damage recovery and joint discomfort simultaneously — inhibiting prostaglandin production (COX-2), leukotriene synthesis (5-LOX via Boswellia AKBA), and pro-inflammatory cytokine signaling (NF-κB). This multi-pathway approach addresses the full inflammatory cascade from exercise-induced muscle damage and joint stress, producing the rapid onset (5 days for joint comfort) observed in clinical studies.

1
Dynagenix® Joint Comfort — Clinical Study (5-Day Onset)
PubMed

Published clinical study demonstrating Dynagenix® joint comfort improvements within 5 days. PLT Health Solutions second clinical study on beverage-friendly Dynagenix® formula.

Active adults with joint discomfort. Placebo-controlled design.

Dynagenix® produced significant joint comfort improvement within 5 days vs. placebo. Enhanced mobility and functional movement at all assessment timepoints. Beverage-stable formulation maintained efficacy in liquid delivery systems. Published October 2025.

2
Dynagenix® Muscle Recovery — Clinical Study
PubMed

Randomized clinical study examining Dynagenix® effects on exercise-induced muscle damage recovery, soreness, and range of motion.

Active adults. Exercise-induced muscle damage protocol.

Dynagenix® significantly accelerated muscle recovery, reduced soreness scores, and improved range of motion vs. control following exercise-induced muscle damage protocol. Both muscle and joint benefits confirmed in separate clinical studies.

Common Potential side effects

Beverage-compatible formula — designed for excellent organoleptic profile
Botanically-derived — generally well tolerated
Component-specific considerations per full formulation disclosure

Important Drug interactions

Anti-inflammatory medications — complementary mechanism; generally safe but monitor
Anticoagulants — Boswellia component has mild antiplatelet activity; monitor